Prototype Information Disclosure

March 26, 2026

Disclosure of Information or Other Material Event

November 18, 2025

Disclosure of Information or Other Material Event

September 4, 2025

Changes to the Composition of the Audit Committee

August 15, 2025

Change of Head of Internal Audit Unit of PT Pyridam Farma Tbk

June 20, 2025

Material Information or Facts regarding the Changes to Board of Directors and Board of Commissioners of the Company

June 5, 2025

PUBLIC EXPOSE (“PUBLIC EXPOSE”) PT PYRIDAM FARMA TBK

April 10, 2025

Material Information or Facts regarding the Reporting of Changes to the Board of Directors of Controlled Entity

April 8, 2025

Material Information or Facts regarding the Reporting of Changes to the Board of Directors of Controlled Entity

February 20, 2025

Changes to the Composition of the Audit Committee

February 19, 2025

Material Information or Facts regarding the Passing of an Independent Commissioner of PT Pyridam Farma Tbk.

February 3, 2025

Material Information regarding the Signing of Credit Agreement between PT Ethica Industri Farmasi and PT Bank Mandiri (Persero) Tbk

December 6, 2024

Information Disclosure on Material Transaction

October 10, 2024

INCIDENTAL PUBLIC EXPOSE OF PT PYRIDAM FARMA TBK

August 23, 2024

Change of Corporate Secretary of PT Pyridam Farma Tbk.

July 25, 2024

Information Disclosure on Material Transaction

July 19, 2024

Information Disclosure on Material Transaction

June 27, 2024

Information Disclosure on Material Transaction and Affiliate Transaction

June 20, 2024

Completion of Acquisition of Probiotec Limited by PYFA Australia Pty. Ltd.

June 11, 2024

Capital Increase of PYFA Australia Pty. Ltd.

June 7, 2024

PUBLIC EXPOSE (“PUBLIC EXPOSE”) PT PYRIDAM FARMA TBK

May 24, 2024

Information Disclosure on Material Transaction and Affiliate Transaction

May 24, 2024

Acquisition of PYFA Australia Pty. Ltd. by PYFA Health Singapore Pte. Ltd.

May 8, 2024

Information Disclosure on Material Transaction

April 24, 2024

Information Disclosure on changes to Board of Directors of Subsidiary (PT Pyfa Sehat Indonesia)

March 22, 2024

Information Disclosure on Material Transaction

January 3, 2024

Transfer of Shares in PT Mega Inter Distrindo

December 21, 2023

The Signing of Scheme Implementation Deed

November 7, 2023

Information Disclosure on Subsidiary Establishment

October 4, 2023

Bond Repayment Information Disclosure

June 9, 2023

PUBLIC EXPOSE (“PUBLIC EXPOSE”) PT PYRIDAM FARMA TBK

June 7, 2023

Information Disclosure of Material Transaction

July 19, 2022

POSTPONEMENT PUBLIC EXPOSE (“PUBLIC EXPOSE”) PT PYRIDAM FARMA TBK

July 7, 2022

PUBLIC EXPOSE (“PUBLIC EXPOSE”) PT PYRIDAM FARMA TBK

April 5, 2022

PT Pyridam Farma Tbk Enters into a Marketing and Promotion Services Agreement with Mundhipharma Healthcare Indonesia

March 2, 2022

Prospectus of Public Offering of Pyridam Farma Bond I 2022

March 1, 2022

Additional Information of Abridged Prospectus of Public Offering of Pyridam Farma Bond I 2022

February 12, 2022

Abridged Prospectus of Public Offering of Pyridam Farma Bond I 2022

January 4, 2022

Information Disclosure of Material Transactions for Capital Increase of PT Holi Pharma

December 30, 2021

Completion of the Share Takeover Transaction at PT Holi Pharma by PT Pyridam Farma Tbk

December 30, 2021

OCBC Loans for PT Pyridam Farma Tbk and PT Holi Pharma

November 30, 2021

Report of Annual Rating (Obligasi Pyridam Farma I Tahun 2020)

November 24, 2021

Change of Head of Internal Audit Unit of PT Pyridam Farma Tbk.

August 26, 2021

Information Disclosure

August 12, 2021

Public Expose Announcement

July 15, 2021

The Increase of PT Bank OCBC NISP Tbk’s Loan Facility

June 7, 2021

The Completion of the Subscription of New Shares in the Fullerton Health Indonesia Group by PT Pyfa Investama Medika

April 29, 2021

PT Pyridam Farma Tbk. Enters into A Cooperation Agreement with LG International Corp.

April 23, 2021

Signing of Four Shares Subscription Agreements by PT Pyfa Investama Medika to Subscribe New Shares in the Fullerton Health Indonesia Group

March 25, 2021

Establishment of Four Subsidiaries in Indonesia

February 25, 2021

The Opening of Representation Office in South Korea

January 5, 2021

Prospectus of Public Offering of Pyridam Farma Bond I 2020

January 5, 2021

Additional Information and/or Revision of the Abridged Prospectus of Public Offering of Pyridam Farma Bond I 2020

December 17, 2020

Abridged Prospectus of Public Offering of Pyridam Farma Bond I 2020

November 27, 2020

Change of The Company’s Logo of PT Pyridam Farma Tbk.

November 5, 2020

Change of Corporate Secretary of PT Pyridam Farma Tbk.

October 19, 2020

Report of the Mandatory Tender Offer Result

October 14, 2020

Non-binding Memorandum of Understanding in Relation to a Proposed Partnership for the Commercialization and Manufacture of Covid-19 Vaccine

September 18, 2020

Investment in the Subsidiary: Pyfa Health Singapore Pte. Ltd.

September 7, 2020

Information Disclosure on the Mandatory Tender Offer

July 22, 2020

The Change of the Company’s Controller